Andere Kunden interessierten sich auch für
![The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America]( "The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America")
The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America69,99 €![Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America]( "Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America")
Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America69,99 €![Breast Cancer, An Issue of Hematology/Oncology Clinics of North America]( "Breast Cancer, An Issue of Hematology/Oncology Clinics of North America")
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America59,99 €![Global Hematology, An Issue of Hematology/Oncology Clinics of North America]( "Global Hematology, An Issue of Hematology/Oncology Clinics of North America")
Global Hematology, An Issue of Hematology/Oncology Clinics of North America69,99 €![Gene Therapy, An Issue of Hematology/Oncology Clinics of North America]( "Gene Therapy, An Issue of Hematology/Oncology Clinics of North America")
Gene Therapy, An Issue of Hematology/Oncology Clinics of North America69,99 €![Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America]( "Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America")
Prostate Cancer, An Issue of Hematology/Oncology Clinics of North America59,99 €![Transfusion Medicine, An Issue of Hematology/Oncology Clinics of North America]( "Transfusion Medicine, An Issue of Hematology/Oncology Clinics of North America")
Transfusion Medicine, An Issue of Hematology/Oncology Clinics of North America69,99 €
This issue of Hematology/Oncology Clinics, edited by Drs. Jorge J. Castillo, Efstathios Kastritis, and Steven P. Treon, will focus on Waldenström Macroglobulinemia. Topics include, but are not limited to, Genomics; Epigenomics; Flow cytometry; Marrow microenvironment; Familial Waldenstrom; MYD88 L265P and other MYD88 mutations; CXCR4 and other recurrent mutations; Diagnosis and differential diagnosis; Criteria to treat and treatment goals; Alkylators; Monoclonal antibodies; Proteasome inhibitors; BTK inhibitors; Transplant; and Novel approaches.